L01XA Platinum compounds, antineoplastic drugs
ATC group of level 4 – chemical subgroup · in plain English: cancer medicines
This site has the patient leaflet or the SPC of 11 medicines in this group and its subgroups.
- 1 no longer supplied or not available
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01X Other antineoplastic agents 225 medicines
-
L01XA Platinum compounds, antineoplastic drugs 11 medicines
- L01XA01 cisplatin 3 medicines
- L01XA02 carboplatin 3 medicines
- L01XA03 oxaliplatin 5 medicines
-
L01XA Platinum compounds, antineoplastic drugs 11 medicines
- L01X Other antineoplastic agents 225 medicines
- L01 Antineoplastic agents 1,025 medicines
2 more subgroups have no medicine with a leaflet on this site.
Active substances in the group
- Carboplatin 3 medicines
- Cisplatin 3 medicines
- Oxaliplatin 5 medicines
Medicines in the group and its subgroups
| Medicine | Legal category |
|---|---|
| Carboplatin 10 mg / ml concentrate for solution for infusion SPC (L01XA02 carboplatin) | – |
| Carboplatin concentrate for infusion 10 mg / ml SPC (L01XA02 carboplatin) | – |
| Carboplatin Venus Pharma 10 mg/ml concentrate for solution for infusion SPC (L01XA02 carboplatin) | – |
| Cisplatin 1 mg / ml concentrate for solution for infusion SPC (L01XA01 cisplatin) | – |
| Cisplatin 1 mg/ml Sterile concentrate (L01XA01 cisplatin) | – |
| Cisplatin Venus Pharma 1 mg/ml concentrate for solution for infusion SPC (L01XA01 cisplatin) | – |
| Eloxatin 5 mg / ml concentrate for solution for infusion SPC no longer supplied (L01XA03 oxaliplatin) | – |
| Oxaliplatin 5 mg / ml concentrate for solution for infusion SPC (L01XA03 oxaliplatin) | – |
| Oxaliplatin 5 mg / ml powder for solution for infusion SPC (L01XA03 oxaliplatin) | – |
| Oxaliplatin Hospira 5 mg / ml concentrate for solution for infusion SPC (L01XA03 oxaliplatin) | – |
| Oxaliplatin Medac 5 mg / ml concentrate for solution for infusion SPC (L01XA03 oxaliplatin) | – |
Other groups of the same level
- L01XB Methylhydrazines, antineoplastics 1 medicine
- L01XC Monoclonal antibodies, antineoplastic 73 medicines
- L01XD Sensitizers used in photodynamic/radiation therapy 10 medicines
- L01XF Retinoids for cancer treatment 2 medicines
- L01XG Proteasome inhibitors, antineoplastic agent 43 medicines
- L01XH Histone deacetylase (HDAC) inhibitors 3 medicines
- L01XJ Hedgehog pathway inhibitors 4 medicines
- L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors 13 medicines
- L01XX Other antineoplastic agents 59 medicines
- L01XY Combinations of antineoplastic agents 4 medicines
Other names of the ATC group
- Czech: L01XA Platinová cytostatika
- French: L01XA dérivés du platine
- German: L01XA Platin-haltige Verbindungen
- Spanish: L01XA COMPUESTOS DE PLATINO (ANTINEOPLASICOS)
- German: L01XA Platin-haltige Verbindungen
- Italian: L01XA COMPOSTI DEL PLATINO
- Polish: L01XA Cytostatyki platyny
- Turkish: L01XA Platin bileşikleri, antineoplastik ilaçlar
- Portuguese (Brazil): L01XA Compostos de platina
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01XA
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.